Dyslipidemias: all 1,101 studies
Page 11 of 12. Open to participants first (161), then studies with results posted, then the rest; newest registration first within each.
- The Effects of Natural Versus Man-Made Trans Fatty Acids on Lipoprotein Profiles: A Pilot StudyCompletedNCT00535886Not applicable
- Crestor RUSH (The Efficacy of RosUvaStatin for Korean Dyslipidemia Patients With Hypertension )CompletedNCT00526708
- The Use of Irvingia Gabonensis (Bush Mango)and Cissus Quadrangularis to Reduce Weight and Blood LipidsCompletedNCT00526682Not applicable
- Crestor RAPID (The Efficacy of RosuvAstatin for Korean Dyslipidemia PatIents With Diabetes)CompletedNCT00526552
- Dietary Protein and Insulin Sensitivity StudyCompletedNCT00508937Not applicable
- Evaluate the Efficacy and Safety of Rosuvastatin Versus Simvastatin in Type 2 Diabetic Patients With DyslipidemiaCompletedNCT00506961Phase 4
- ProAlgaZyme Novel Algae Infusion: Applications in ImmunodeficiencyCompletedNCT00493506Not applicable
- Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and DyslipidemiaCompletedNCT00490178Phase 3
- Study Of Pharmacokinetics and Pharmacodynamics Effects Of GSK256073A On Healthy VolunteersCompletedNCT00488449Phase 1
- Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary DyslipidemiaCompletedNCT00487994Phase 3
- An Evaluation of Simvastatin Plus Omacor Compared to Simvastatin Plus Placebo in Subjects With Mixed DyslipidemiaCompletedNCT00487591
- Lifestyle Intervention in Primary Health Care - the Björknäs StudyCompletedNCT00486941Phase 3
- Atorvastatin Treatment to Attenuate the Progression of Cardiovascular Disease in Hemodialysis PatientsCompletedNCT00481364Phase 3
- Nutritional Treatment of Overweight Adolescents With Cardiovascular Risk Factors (PowerUp)TerminatedNCT00477477Not applicable
- Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia.CompletedNCT00474864Phase 2
- Efficacy and Safety of Berberine in the Treatment of Diabetes With DyslipidemiaCompletedNCT00462046Phase 3
- Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk FactorsTerminatedNCT00458081Phase 3
- Effect of Atazanavir on Endothelial Function in HIV-Infected PatientsCompletedNCT00447070Phase 4
- Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)CompletedNCT00442845Phase 4
- Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol TargetsCompletedNCT00442325Phase 4
- Effect of Abdominal Obesity on Lipoprotein MetabolismCompletedNCT00438061Phase 3
- Japanese Study of Rimonabant in Obese Patients With Dyslipidemia (VENUS)TerminatedNCT00434096Phase 3
- Effect of Omega -3 Fatty Acids Supplements and Plant Sterol Enriched Food in Dyslipidemic AdultsCompletedNCT00422266Phase 3
- Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 DiabetesCompletedNCT00419484
- European Trial About Effect of RimoNabant on Abdominal Obese Patients With dysLipidemiaTerminatedNCT00412698Phase 3
- Guidelines Based Undertaking for Improvement in Dyslipidemia Related Events (GUIDE )CompletedNCT00408057
- MARIS Study; Mediterranean Approach to Reduce Insulin-Resistance StudyCompletedNCT00405197Not applicable
- Efavirenz to Nevirapine Switch and Low-Density Lipoprotein (LDL)-DyslipidemiaCompletedNCT00405171Phase 4
- The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) StudyCompletedNCT00400231Phase 2
- Regulation of Lipoprotein Metabolism in Obese MenCompletedNCT00392717Phase 3
- An Exploratory Study To Look At The Effect Of Two Investigational Drugs On Body Fat And InflammationCompletedNCT00388180
- Efficacy and Safety of Valsartan and the Combination of Valsartan and SimvastatinCompletedNCT00385931Phase 3
- Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic SyndromeCompletedNCT00385658Phase 4
- A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and DyslipidemiaCompletedNCT00379756Phase 4
- Rajavithi Health Promotion Project (Population Base Cohort)Active, not recruitingNCT00368095
- Effects of Low and Moderate Fat Diets on Lipids, Inflammation and Vascular Reactivity in the Metabolic SyndromeCompletedNCT00362908Not applicable
- Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics StudyTerminatedNCT00362765Phase 2/3
- Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFOCompletedNCT00362323Phase 3
- Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSITerminatedNCT00361868Phase 3
- Strategies to Maintain Cardiac Risk Control After Discharge From Cardiovascular Risk Reduction ClinicCompletedNCT00358033Phase 3
- Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial FunctionsCompletedNCT00350038Phase 4
- Fenofibrate in Dyslipidemia and Metformin-Controlled DiabetesCompletedNCT00349128Phase 2/3
- CholGate - The Effect of Alerting Versus on Demand Computer Based Decision Support on Treatment of Dyslipidaemia by General PractitionersCompletedNCT00348751Not applicable
- Acceptability of a Fixed Combination of Fenofibrate and MetforminCompletedNCT00348725Phase 3
- Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual CareCompletedNCT00345657Phase 4
- Dose-Ranging Study Evaluating AVE1625 in Abdominally Obese Patients With Atherogenic DyslipidemiaCompletedNCT00345410Phase 2
- MK0354 Clinical Efficacy and Tolerability Study (0354-004)TerminatedNCT00337415Phase 2
- Caduet in an Untreated Subject PopulationCompletedNCT00332761Phase 4
- Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and DyslipidemiaCompletedNCT00331487Phase 3
- Effects of Statin Medications on Mental Processes, Behavior, and Serotonin LevelsCompletedNCT00330980Phase 4
- Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and DyslipidaemiaCompletedNCT00330785Phase 3
- Effectiveness of Nigella Sativa (Kalonji) Seed in DyslipidemiaCompletedNCT00327054Phase 1/2
- Effect of CP-778,875 on HDL-C in Subjects With Abnormal Lipid Levels and Type 2 Diabetes.CompletedNCT00326326Phase 2
- Effect Of GW501516X On How The Heart Obtains And Uses EnergyTerminatedNCT00318617
- Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and HypercholesterolemiaCompletedNCT00316095Phase 3
- Diabetes and Combined Lipid Therapy Regimen (DIACOR) StudyCompletedNCT00309712Not applicable
- Study of Niacin and Rosiglitazone in Dysmetabolic DyslipidemiaCompletedNCT00304993Phase 4
- Atorvastatin Versus Ezetimibe and Fenofibrate as a Lipid-lowering StrategyCompletedNCT00299884
- The Use of Magnesium to Improve Blood Pressure, Cholesterol, and Glucose ControlCompletedNCT00282659Phase 4
- Omentectomy for the Treatment of Diabetes Mellitus Type 2CompletedNCT00270439Phase 1
- Efficacy of Lapaquistat Acetate Alone and With Ezetimibe in Subjects With Primary Dyslipidemia.CompletedNCT00268697Phase 3
- A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol (A5091031).TerminatedNCT00267280Phase 3
- A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder.TerminatedNCT00267267Phase 3
- A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol.CompletedNCT00267254Phase 3
- Cardiovascular Risk Factor Management in HIV InfectionCompletedNCT00264394Phase 4
- Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia.CompletedNCT00256178Phase 3
- Evaluation of Combination Cholesterol Treatments in Patients With High Cholesterol.CompletedNCT00249938Phase 4
- Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed DyslipidemiaCompletedNCT00245388Phase 2/3
- A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic SyndromeCompletedNCT00240305Phase 3
- Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT)CompletedNCT00240266Phase 3
- An International Study of Rimonabant in Dyslipidemia With AtheroGenic Risk In Abdominally Obese PatientsCompletedNCT00239967Phase 3
- A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With DyslipidemiaTerminatedNCT00231621Phase 3
- Effective Endurance Training in Metabolic SyndromeCompletedNCT00218998Not applicable
- Effect of a Decision Aid About Statin Use in Patients With Type 2 Diabetes MellitusCompletedNCT00217061Phase 3
- SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in HyperlipidemiaCompletedNCT00194402Phase 4
- Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy SubjectsCompletedNCT00192621Phase 4
- Treatment of Insulin Resistance in Hypertensive, Obese AdolescentsTerminatedNCT00185705Not applicable
- Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.CompletedNCT00174304Phase 4
- Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial DysfunctionCompletedNCT00171327Phase 4
- Efficacy and Safety Study of Fluvastatin and Ezetimibe Combined Versus Fluvastatin AloneCompletedNCT00171288Phase 3
- Trial to Evaluate the Efficacy of Fluvastatin on Certain MarkersCompletedNCT00171262Phase 4
- Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial HypercholesterolemiaCompletedNCT00171236Phase 3
- Hs-CRP as Clinical Marker of Inflammatory Atherogenic DyslipidemiaCompletedNCT00169871
- Dyslipidemia Study Investigating The Increase In "Good Cholesterol"CompletedNCT00169559Phase 2
- GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein CholesterolCompletedNCT00158899Phase 2
- Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient PopulationCompletedNCT00150384Phase 4
- Influence of Pravastatin on Carotid Artery Structure and Function in HIV-infected Patients Under Antiretroviral TherapyCompletedNCT00147797
- Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated CholesterolCompletedNCT00143663Phase 3
- Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary HypercholesterolemiaCompletedNCT00136799Phase 3
- Fluvastatin in Adults With Dislipidemia With History of Muscle ProblemsCompletedNCT00125125Phase 4
- A Study in People With Abnormal Fat Levels in the BloodCompletedNCT00116519Phase 2
- An Investigational Drug Study Evaluating a Novel Approach to Treat Dyslipidemia (0524A-032)CompletedNCT00111891Phase 2
- Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug TherapyCompletedNCT00109603Not applicable
- Effect of Diet on Men and Women With Genetic Alterations Associated With Abnormal Blood TestsCompletedNCT00108212Not applicable
- Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOASTCompletedNCT00082251Phase 3
- Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients With Dyslipidemia (OCEANS)CompletedNCT00080275Phase 3
- Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELLCompletedNCT00079638Phase 4
- A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and YouthCompletedNCT00069004
- Obese Patients With Untreated DyslipidemiasCompletedNCT00029835Phase 3
- Cardiovascular Evaluation of Patients With High Cholesterol and Normal VolunteersCompletedNCT00001204